Centinel Spine Inc. Announces Exclusive US- Distribution Rights of STALIF TT Stand Alone Lumbar IBF Device

MINNEAPOLIS--(BUSINESS WIRE)--Centinel Spine, Inc. announced today that further to its strategic integration plan with Surgicraft Group Holdings Limited (Surgicraft), Centinel Spine has retained exclusive US-Distribution Rights to the STALIF TT™ Stand Alone Lumbar Interbody Fusion Device Technology with immediate effect. As a consequence, Centinel Spine now has exclusive distribution rights to market STALIF TT™ products in all markets & countries globally. Centinel Spine expects to see increased revenue from this technology as early as Q1 of 2009.

“The addition of the STALIF TT™ system to our product portfolio continues our winning formula of No Profile stand alone interbody fusion technologies. It allows The Company to benefit from the strengths of the STALIF TT™ technology in the form of tried and true proven scientific and clinical outcomes. With our improved and rapidly expanding distribution channels the STALIF TT™ will allow Centinel to significantly increase revenue while benefiting patients throughout the United States,” explained John J. Viscogliosi, Chairman & CEO of Centinel Spine. “This is a tremendously exciting time for Centinel Spine as we continue to identify opportunities to expand our market reach both domestically and internationally.”

“This integration represents a unique consolidation of STALIF TT™ & STALIF C™ technologies which will continue to help transform Centinel Spine into a worldwide leader, while substantially furthering our strategy of building a leading on-the-ground presence in the United States,” said Craig Corrance, President of Centinel Spine. “We are most excited about the enormous sales potential that the STALIF TT™ system presents to our Company.” Mr. Corrance continued “Centinel Spine now has one of the larger independent sales distribution channels in the US Spinal markets a well respected reputation in the Fusion (IBF) marketplace and a significant foundation to rapidly build upon.”

About Centinel Spine, Inc.

Centinel Spine, Inc. is a leading global medical device company providing the PEEK-OPTIMA® STALIF TT™ and STALIF C™ technologies for Stand Alone Interbody Fusion (IBF) procedures. The STALIF TT™ and STALIF C™ technologies have been used in nearly 10,000 patients worldwide. The Company is dedicated to “Transforming Spine Surgeons’ Ideas into Tomorrow’s Technology.” For more information, visit the Company website: www.centinelspine.com

Contact:

Centinel Spine, Inc. John J. Viscogliosi, CEO, 773-230-0366

Source: Centinel Spine, Inc.